2014 Pharma Manufacturing Investments Reflect Key Industry Trends Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments. Pharmaceutical Technology’s Cynthia Challener offers summary of selected investments in both small- and large-molecule manufacturing facilities during the last year. Read more
Ebola Debates Turn Everyone into an Expert All of a sudden, the mass media and social networks are reflecting wide public demands for more action on drug development—instead of the customary complaints that drug firms are merely cynical money-making machines. Peter O’ Donnell reports... Read more
The History (and Future) of Pharma M&As As the pharmaceutical market expands internationally, companies have realised that carefully thought-out M&As can open up new geographical advantages. Although the pharma markets of US, Europe and Japan still represent the majority of global sales, emerging markets are growing at a faster annual rate, writes Faiz Kermani ... Read more
mHealth Set to Transform Clinical Trials mHealth technologies hold great potential to transform clinical development programs, including clinical trials, and they can drive much-needed transformation with regard to improving the fundamental quality of clinical trial data, writes Mukhtar Ahmed.... Read more
Pharm Exec’s Emerging Pharma Leaders 2014 This year's class of 15 young executives is deeply of the moment, with wide-ranging therapeutic, business, and operational expertise — all binded by an underlying commitment to the patient.... Read more
